Optimizing criteria for N-terminal pro-B-type natriuretic peptide for eligibility and enrichment in trials in heart failure with preserved, mid-range and reduced ejection fraction
26 May 2018 (00:00 - 00:00)
Organised by:
About the speaker

Karolinska Institute, Stockholm (Sweden)
5 More presentations in this session
Professor C. Chavez-Mendez (Mexico City, MX)
Associate Professor S. Cho (Goyang, KR)
Mr N. Marcks (Maastricht, NL)
Doctor D. Bodez (Creteil, FR)
Access the full session
The Event
Heart Failure 2018
26 May - 29 May 2018
